NEO:CYBN ▲
NEO:CYBN ▲

A LEADING BIOTECHNOLOGY COMPANY ON
A MISSION TO ERADICATE MENTAL ILLNESS.

A LEADING BIOTECHNOLOGY COMPANY ON A MISSION TO ERADICATE MENTAL ILLNESS.

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

CYBIN X KERNEL

A NEW FRONTIER IN PSYCHEDELIC THERAPEUTICS

Cybin will leverage Kernel’s Flow to quantify brain activity during psychedelic experiences in real time, adding an exciting dimension to its investigative work focused on developing breakthrough therapeutics for mental health disorders. READ MORE

LEARN MORE

KEEP IN TOUCH

Cybin is a biotechnology company focused on progressing psychedelics therapeutics. 

5600-100 King St W, Toronto,
ON M5X 1C9

Linkedin
Facebook
Twitter
Envelope
PRIVACY POLICY

© Cybin INC. 2019 All rights reserved.